Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment has been made of clinical impact, treatment timings and associated costs for the NHS resulting from the closure of Rutherford Health centres, including the Bomarsund site.

The Department did not provide an assessment of the cost, clinical impact, or NHS England’s treatment timelines associated with transitioning patients from Rutherford Health centres. This includes the Bomarsund site, prior to the organisation's liquidation. The Government is committed to improving performance for diagnosing and treating cancer. To support these objectives, the National Health Service is currently making use of two of the five former Rutherford Cancer sites, Taunton and Clatterbridge.